Evidence map›Paper›PMID 31031735›Full record

ArticleFrontiers in microbiology2019

Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC.

Alessia Lai, Francesco Roberto Simonetti, Gaetano Brindicci, Annalisa Bergna, Simona Di Giambenedetto, Gaetana Sterrantino, Cristina Mussini, Stefano Menzo, Patrizia Bagnarelli, Maurizio Zazzi and 4 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alessia LaiDepartment of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Francesco Roberto SimonettiDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Gaetano BrindicciClinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy.
Annalisa BergnaDepartment of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Simona Di GiambenedettoInstitute of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy.
Gaetana SterrantinoDivision of Tropical and Infectious Diseases, Careggi Hospital, Florence, Italy.
Cristina MussiniClinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
Stefano MenzoUnit of Virology, Azienda Ospedaliero-Universitaria 'Ospedali Riuniti', Torrette, Italy.
Patrizia BagnarelliUnit of Virology, Azienda Ospedaliero-Universitaria 'Ospedali Riuniti', Torrette, Italy.
Maurizio ZazziDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Gioacchino AngaranoClinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy.
Massimo GalliDepartment of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Laura MonnoClinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy.
Claudia BalottaDepartment of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular epidemiology of HIV-1 in Italy is becoming increasingly complex, mainly due to the spread of non-B subtypes and the emergence of new recombinant forms. We previously characterized the outbreak of the first Italian circulating recombinant form (CRF60_BC), occurring among young MSM living in Apulia between the years 2009 and 2011. Here we show a 5-year follow-up surveillance to trace the evolution of CRF60_BC and to investigate its further spread in Italy. We collected additional sequences and clinical data from patients harboring CRF60_BC, enrolled at the Infectious Diseases Clinic of the University of Bari. In addition to the 24 previously identified sequences, we retrieved 27 CRF60_BC sequences from patients residing in Apulia, whose epidemiological and clinical features did not differ from those of the initial outbreak, i.e., the Italian origin, young age at HIV diagnosis (median: 24 years; range: 18-37), MSM risk factor (23/25, 92%) and recent infection (from 2008 to 2017). Sequence analysis revealed a growing overall nucleotide diversity, with few nucleotide changes that were fixed over time. Twenty-seven additional sequences were detected across Italy, spanning multiple distant regions. Using a BLAST search, we also identified a CRF60_BC sequence isolated in United Kingdom in 2013. Three patients harbored a unique second generation recombinant form in which CRF60_BC was one of the parental strains. Our data show that CRF60_BC gained epidemic importance, spreading among young MSM in multiple Italian regions and increasing its population size in few years, as the number of sequences identified so far has triplicated since our first report. The observed further divergence of CRF60_BC is likely due to evolutionary bottlenecks and host adaptation during transmission chains. Of note, we detected three second-generation recombinants, further supporting a widespread circulation of CRF60_BC and the increasing complexity of the HIV-1 epidemic in Italy.

Indexed as

HIV-1 evolutionHIV-1 molecular epidemiologyHIV-1 outbreakHIV-1 recombinant formssecond generation recombinants

Identifiers

PMID31031735
PMCPMC6474184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.